Form 4: Alphatec Holdings Director Receives Stock Grant Under Consulting Agreement

Sentiment:

SEC Form 4 Filing


David M. Demski, a director at Alphatec Holdings, received 126,051 restricted stock units (RSUs) as part of a consulting agreement.

Summary

  • David M. Demski, a director of Alphatec Holdings, Inc., was granted 126,051 restricted stock units (RSUs) on December 18, 2024.
  • The RSUs were granted as consideration for services to be provided under a consulting agreement.
  • The RSUs vest in equal 25% increments on June 30 of each year from 2025 to 2028.
  • If the consulting agreement is terminated before June 30, 2028, unvested RSUs will vest on a pro-rata basis based on the number of days elapsed since the last vesting date.
  • Any RSUs not vested after the pro-rata calculation will be forfeited.
  • Each RSU represents a contingent right to receive one share of Alphatec Holdings' common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning interests, but does not contain any extraordinary news.

Positives

  • The grant of RSUs aligns the director's interests with the company's long-term performance.
  • The vesting schedule encourages continued service and contribution from the director.
  • The pro-rata vesting clause provides flexibility in case of early termination of the consulting agreement.

Risks

  • The value of the RSUs is subject to the volatility of Alphatec Holdings' stock price.
  • The director may forfeit unvested RSUs if the consulting agreement is terminated before the full vesting period.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service under the consulting agreement.

Industry Context

The use of stock-based compensation is common in the industry to align the interests of directors and management with shareholders.

Comparison to Industry Standards

  • Stock grants to directors are a standard practice in publicly traded companies, particularly in the biotech and medical device sectors.
  • Vesting schedules are typically structured to incentivize long-term commitment and performance.
  • The pro-rata vesting clause is a common feature to address early termination scenarios.

Stakeholder Impact

  • The stock grant may have a minor dilutive effect on existing shareholders.
  • The vesting schedule incentivizes the director to contribute to the company's long-term success.

Key Dates

DateDescription
12/18/2024Date of the RSU grant and consulting agreement.
06/30/2025First vesting date for 25% of the RSUs.
06/30/2026Second vesting date for 25% of the RSUs.
06/30/2027Third vesting date for 25% of the RSUs.
06/30/2028Final vesting date for the remaining 25% of the RSUs.

Keywords

restricted stock units, RSUs, consulting agreement, stock grant, director, Alphatec Holdings, vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.